These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35339296)

  • 1. LDL as a therapeutic target.
    Díaz Rodríguez Á; Mantilla Morató T
    Clin Investig Arterioscler; 2022; 34(5):271-284. PubMed ID: 35339296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDL as a therapeutic objective.
    Díaz Rodríguez Á; Mantilla Morató T
    Clin Investig Arterioscler; 2019 Dec; 31 Suppl 2():1-15. PubMed ID: 31813617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Guidelines for the management of dyslipidemia].
    Díaz Rodríguez Á;
    Semergen; 2014 Sep; 40 Suppl 4():19-25. PubMed ID: 25595349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dyslipidemias and statins: from guidelines to clinical practice. An updated review of the literature].
    Lucchi T; Vergani C
    G Ital Cardiol (Rome); 2014 Mar; 15(3):149-60. PubMed ID: 24770428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Low-density Lipoprotein Cholesterol Target Attainment Rates According to the 2016 and 2019 European Society of Cardiology/European Atherosclerosis Society Dyslipidemia Guidelines for Secondary Prevention in Patients with Acute Myocardial Infarction.
    Şimşek B; İnan D; Çınar T; Cagdas-Yumurtaş A; Ozan-Tanık V; Zeren G; İlker-Avcı İ; Yücel-Karabay C; Güngör B; Tokgozoğlu L
    Rev Invest Clin; 2021 Nov; 73(3):371-378. PubMed ID: 34098569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How Did the Updated 2019 European Society of Cardiology/European Atherosclerosis Society Risk Categorization for Patients with Diabetes Affect the Risk Perception and Lipid Goals? A Simulated Analysis of Real-life Data from EPHESUS Study.
    Başaran Ö; Doğan V; Mert KU; Özlek B; Özlek E; Çelik O; Çil C; Özdemir İH; Rencüzoğulları İ; Özpamuk Karadeniz F; Tekinalp M; Aşkın L; Demirelli S; Gencer E; Bekar L; Aktaş M; Resulzade MM; Kalçık M; Aksan G; Çinier G; Halil Akay K; Pekel N; Mert GÖ; Şenol U; Demir V; İnci S; Derviş E; Biteker M; Kayıkçıoğlu M
    Anatol J Cardiol; 2023 Feb; 27(2):78-87. PubMed ID: 36747449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Optimal cholesterol levels in patients in real-life. A systematic review].
    Escobar C; Barrios V; Pérez de Isla L
    Semergen; 2018; 44(1):42-49. PubMed ID: 29153337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and LDL-C management in a cohort of high and very high cardiovascular risk patients: The PORTRAIT-DYS study.
    Gavina C; Seabra-Carvalho D; Aguiar C; Anastassopoulou A; Teixeira C; Ruivo JA; Almeida É; Luz-Duarte L; Corte-Real A; Canelas-Pais M; Taveira-Gomes T
    Clin Cardiol; 2024 Jan; 47(1):e24183. PubMed ID: 37933175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of application of the new 2019 European Society of Cardiology/ European Atherosclerosis Society Guidelines for the Management of Dyslipidaemias in daily clinical practice - one center study.
    Cecha P; Chromik A; Piotrowska I; Zabojszcz M; Dolecka-Ślusarczyk M; Siudak Z
    Folia Med Cracov; 2021 Sep; 61(3):43-54. PubMed ID: 34882663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achievement rates of Japan Atherosclerosis Society Guidelines 2007 LDL-cholesterol goals with rosuvastatin or atorvastatin in patients who had not achieved their goal with atorvastatin.
    Shioji K; Izuhara M; Mitsuoka H; Uegaito T; Matsuda M;
    Cardiovasc Ther; 2014 Jun; 32(3):97-104. PubMed ID: 24456217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins and PCSK9 inhibitors: A new lipid-lowering therapy.
    Gallego-Colon E; Daum A; Yosefy C
    Eur J Pharmacol; 2020 Jul; 878():173114. PubMed ID: 32302598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimizing Dyslipidemia Management for the Prevention of Cardiovascular Disease: a Focus on Risk Assessment and Therapeutic Options.
    Berman AN; Blankstein R
    Curr Cardiol Rep; 2019 Aug; 21(9):110. PubMed ID: 31378838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2022 Taiwan lipid guidelines for primary prevention.
    Huang PH; Lu YW; Tsai YL; Wu YW; Li HY; Chang HY; Wu CH; Yang CY; Tarng DC; Huang CC; Ho LT; Lin CF; Chien SC; Wu YJ; Yeh HI; Pan WH; Li YH;
    J Formos Med Assoc; 2022 Dec; 121(12):2393-2407. PubMed ID: 35715290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Clinical Guide to Combination Lipid-Lowering Therapy.
    Russell C; Sheth S; Jacoby D
    Curr Atheroscler Rep; 2018 Mar; 20(4):19. PubMed ID: 29516190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How effective are the ESC/EAS and 2013 ACC/AHA guidelines in treating dyslipidemia? Lessons from a lipid clinic.
    Barkas F; Milionis H; Kostapanos MS; Mikhailidis DP; Elisaf M; Liberopoulos E
    Curr Med Res Opin; 2015 Feb; 31(2):221-8. PubMed ID: 25418708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report.
    Jacobson TA; Ito MK; Maki KC; Orringer CE; Bays HE; Jones PH; McKenney JM; Grundy SM; Gill EA; Wild RA; Wilson DP; Brown WV
    J Clin Lipidol; 2015; 9(2):129-69. PubMed ID: 25911072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persistent dyslipidemia in Austrian patients treated with statins for primary and secondary prevention of atherosclerotic events - Results of the DYSlipidemia International Study (DYSIS).
    Drexel H; Chazelle F; Fauer C; Lautsch D; Gitt AK
    Wien Klin Wochenschr; 2011 Oct; 123(19-20):611-7. PubMed ID: 21947362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Perspectives on the Attainment of Lipid Modification Goals Relating to the Use of Statins and Ezetimibe for the Prevention of Cardiovascular Disease in the United Kingdom.
    Reynolds TM; Pottle A; Quoraishi SH
    Vasc Health Risk Manag; 2021; 17():227-237. PubMed ID: 34054297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.